van der Huizen A A, Wilting T, van de Grampel J C, Lelieveld P, van der Meer-Kalverkamp A, Lamberts H B, Mulder N H
J Med Chem. 1986 Aug;29(8):1341-5. doi: 10.1021/jm00158a003.
A number of recently synthesized mono- and bis(1-aziridinyl) derivatives of the inorganic ring systems (NPCl2)3 and (NPCl2)4 was tested for their cytostatic activity in vitro (L1210 and L5178Y cells) and in vivo (intraperitoneal leukemia L1210 in CDF1 mice). Generally, the nongeminal bis(1-aziridinyl) isomers (either trans or cis) appear to be potent tumor growth inhibitors in contrast to their geminally substituted and mono(1-aziridinyl)-substituted analogues. A relationship between the biological activity and the number of alkylating centers (i.e., P atoms carrying one or two aziridinyl groups) is proposed.
对最近合成的无机环状体系(NPCl2)3和(NPCl2)4的多种单(1-氮丙啶基)和双(1-氮丙啶基)衍生物进行了体外(针对L1210和L5178Y细胞)和体内(CDF1小鼠腹腔内L1210白血病)细胞抑制活性测试。一般来说,与偕二取代和单(1-氮丙啶基)取代类似物相比,非偕二双(1-氮丙啶基)异构体(反式或顺式)似乎是有效的肿瘤生长抑制剂。提出了生物活性与烷基化中心数量(即携带一个或两个氮丙啶基的磷原子)之间的关系。